HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

bosutinib

a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases; structure in first source
Also Known As:
SKI-606; SKI606
Networked: 96 relevant articles (11 outcomes, 30 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Gambacorti-Passerini, Carlo: 16 articles (09/2015 - 02/2006)
2. Boschelli, Frank: 11 articles (01/2015 - 01/2003)
3. Brümmendorf, Tim H: 10 articles (09/2015 - 10/2011)
4. Cortes, Jorge E: 9 articles (09/2015 - 05/2011)
5. Leip, Eric: 8 articles (09/2015 - 10/2011)
6. Kantarjian, Hagop M: 8 articles (09/2015 - 05/2011)
7. Abbas, Richat: 8 articles (03/2015 - 10/2011)
8. Kim, Dong-Wook: 7 articles (09/2015 - 10/2011)
9. Turnbull, Kathleen: 6 articles (09/2015 - 02/2012)
10. Sonnichsen, Daryl: 6 articles (03/2015 - 12/2011)

Related Diseases

1. Myeloid Leukemia (Leukemia, Myelocytic)
2. Breast Neoplasms (Breast Cancer)
3. Leukemia
4. Philadelphia Chromosome
5. BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)

Related Drugs and Biologics

1. imatinib (Gleevec)
2. bosutinib
3. Phosphotransferases (Kinase)
4. Protein-Tyrosine Kinases (Tyrosine Kinase)
5. dasatinib (BMS 354825)
6. 4- methyl- N- (3- (4- methylimidazol- 1- yl)- 5- (trifluoromethyl)phenyl)- 3- ((4- pyridin- 3- ylpyrimidin- 2- yl)amino)benzamide (nilotinib)
7. Hormones
8. Aromatase (CYP19)
9. gefitinib (Iressa)
10. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Drug Therapy (Chemotherapy)
3. Aftercare (After-Treatment)
4. Oral Administration